Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Radionecrosis after stereotactic radiotherapy for brain metastases
E. Le Rhun
*
, F. Dhermain
,
G. Vogin
, N. Reyns
, P. Metellus
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
95
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Radionecrosis after stereotactic radiotherapy for brain metastases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Brain Metastases
100%
Radionecrosis
100%
Stereotactic Body Radiotherapy
100%
Adverse Effects
20%
Area Cover
20%
Bevacizumab
20%
Contrast Enhancement
20%
Edema
20%
Complication Risk
20%
Standard of Care
20%
Irradiation
20%
High-dose Radiation
20%
Corticosteroids
20%
Major Risk
20%
Necrotic Lesion
20%
Radiation Dose
20%
Expert Commentary
20%
Large Volume
20%
Whole-brain Irradiation
20%
Symptom Relief
20%
Medicine and Dentistry
Brain Metastasis
100%
Stereotactic Radiotherapy
100%
Radiation Necrosis
100%
Magnetic Resonance Imaging
20%
Adverse Event
20%
Drug Megadose
20%
Morbidity
20%
Edema
20%
Bevacizumab
20%
Brain Radiation
20%
Corticosteroid
20%
Neuroscience
Radiation Therapy
100%
Magnetic Resonance Imaging
25%
Bevacizumab
25%
Adverse Effect
25%
Corticosteroid
25%
Risk Factor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Radiation Necrosis
100%